Cargando…

Target RNA modification for epigenetic drug repositioning in neuroblastoma: computational omics proximity between repurposing drug and disease

RNA modifications modulate most steps of gene expression. However, little is known about its role in neuroblastoma (NBL) and the inhibitors targeting it. We analyzed the RNA-seq (n=122) and CNV data (n=78) from NBL patients in Therapeutically Applicable Research to Generate Effective Treatments (TAR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Pei, Yue, Lifeng, Zhang, Sen, Hao, Dacheng, Wu, Zhihong, Xu, Lijia, Du, Guanhua, Xiao, Peigen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7732279/ https://www.ncbi.nlm.nih.gov/pubmed/33044945 http://dx.doi.org/10.18632/aging.103671

Ejemplares similares

Drug repositioning or target repositioning: A structural perspective of drug-target-indication relationship for available repurposed drugs
por: Parisi, Daniele, et al.
Publicado: (2020)

Drug Repositioning for Diabetes Based on 'Omics' Data Mining
por: Zhang, Ming, et al.
Publicado: (2015)

Unraveling Gene Fusions for Drug Repositioning in High-Risk Neuroblastoma
por: Liu, Zhichao, et al.
Publicado: (2021)

Drug Repositioning for Alzheimer’s Disease Based on Systematic ‘omics’ Data Mining
por: Zhang, Ming, et al.
Publicado: (2016)

Drug repositioning for dengue haemorrhagic fever by integrating multiple omics analyses
por: Amemiya, Takayuki, et al.
Publicado: (2019)

Computational approaches for drug repositioning and repurposing to combat SARS-CoV-2 infection
por: Panda, Subhamay, et al.
Publicado: (2022)

A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network
por: Jadamba, Erkhembayar, et al.
Publicado: (2016)

Repositioning canakinumab for non-small cell lung cancer—important lessons for drug repurposing in oncology
por: Lythgoe, Mark P., et al.
Publicado: (2022)

Systematic analyses of drugs and disease indications in RepurposeDB reveal pharmacological, biological and epidemiological factors influencing drug repositioning
por: Shameer, Khader, et al.
Publicado: (2017)

Repositioning Drugs for Psychiatry
por: Akhondzadeh, Shahin
Publicado: (2020)

Bexarotene combined with lapatinib for the treatment of Cushing’s disease: evidence based on drug repositioning and experimental confirmation
por: Yu, Haoying, et al.
Publicado: (2020)

Repositioned Drugs for Chagas Disease Unveiled via Structure-Based Drug Repositioning
por: Adasme, Melissa F., et al.
Publicado: (2020)

Drug repositioning in drug discovery of T2DM and repositioning potential of antidiabetic agents
por: Zhu, Sha, et al.
Publicado: (2022)

PharmOmics: A species- and tissue-specific drug signature database and gene-network-based drug repositioning tool
por: Chen, Yen-Wei, et al.
Publicado: (2022)

Application of multiple omics and network projection analyses to drug repositioning for pathogenic mosquito-borne viruses
por: Amemiya, Takayuki, et al.
Publicado: (2021)

Drug repositioning for personalized medicine
por: Li, Yvonne Y, et al.
Publicado: (2012)

Network mirroring for drug repositioning
por: Park, Sunghong, et al.
Publicado: (2017)

Drug Repositioning for COVID-19
por: Benavides-Cordoba, Vicente
Publicado: (2020)

GREP: genome for REPositioning drugs
por: Sakaue, Saori, et al.
Publicado: (2019)

Transcriptome-Guided Drug Repositioning
por: Arakelyan, Arsen, et al.
Publicado: (2019)

Drug Repositioning in Friedreich Ataxia
por: Rufini, Alessandra, et al.
Publicado: (2022)

Drepmel—A Multi-Omics Melanoma Drug Repurposing Resource for Prioritizing Drug Combinations and Understanding Tumor Microenvironment
por: Thompson, Zachary J., et al.
Publicado: (2022)

Multi-Omic Data Interpretation to Repurpose Subtype Specific Drug Candidates for Breast Cancer
por: Turanli, Beste, et al.
Publicado: (2019)

A Novel Pipeline for Drug Repurposing for Bladder Cancer Based on Patients’ Omics Signatures
por: Mokou, Marika, et al.
Publicado: (2020)

Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma
por: McGowan, Erin, et al.
Publicado: (2023)

Designing a Network Proximity-Based Drug Repurposing Strategy for COVID-19
por: Stolfi, Paola, et al.
Publicado: (2020)

Systematic Approach for Drug Repositioning of Anti-Epileptic Drugs
por: Ko, Younhee, et al.
Publicado: (2019)

New drugs are not enough-drug repositioning in oncology: An update
por: Armando, Romina Gabriela, et al.
Publicado: (2020)

DrugCentral 2021 supports drug discovery and repositioning
por: Avram, Sorin, et al.
Publicado: (2020)

Computational Chemogenomics Drug Repositioning Strategy Enables the Discovery of Epirubicin as a New Repurposed Hit for Plasmodium falciparum and P. vivax
por: Ferreira, Letícia Tiburcio, et al.
Publicado: (2020)

Concept Modeling-based Drug Repositioning
por: Patchala, Jagadeesh, et al.
Publicado: (2015)

Overcoming Obstacles to Drug Repositioning in Japan
por: Nishimura, Yuhei, et al.
Publicado: (2017)

Changing Trends in Computational Drug Repositioning
por: Yella, Jaswanth K., et al.
Publicado: (2018)

Review of Drug Repositioning Approaches and Resources
por: Xue, Hanqing, et al.
Publicado: (2018)

The Immunogenetics of Psoriasis and Implications for Drug Repositioning
por: Xu, Xuan, et al.
Publicado: (2017)

Thiopurine Drugs Repositioned as Tyrosinase Inhibitors
por: Choi, Joonhyeok, et al.
Publicado: (2017)

A standard database for drug repositioning
por: Brown, Adam S., et al.
Publicado: (2017)

Repositioning Natural Products in Drug Discovery
por: Rastelli, Giulio, et al.
Publicado: (2020)

Repositioning of Antiparasitic Drugs for Tumor Treatment
por: Li, Yan-Qi, et al.
Publicado: (2021)

Topological network measures for drug repositioning
por: Badkas, Apurva, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gom4suk3mabrvdm9si0i9jj62n